Home Supplements How We Rate Blog
Pausinystalia yohimbe bark extract

Yohimbine

Research reviewed: 1988–2017

Yohimbine (Pausinystalia yohimbe bark extract) is a dietary supplement with 8 published peer-reviewed studies involving 612 participants, researched for Fat Loss, Sexual Function, Exercise Performance and 1 more areas.

8
Studies
612
Participants
1984–2017
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Strong Evidence

Fat Loss

Moderate
3 studies 1 of 3 positive 163 participants

Sexual Function

Moderate
1 study 1 of 1 positive 200 participants

Exercise Performance

Moderate
2 studies 1 of 2 positive 399 participants

Anxiety & Adrenergic Effects

Moderate
2 studies 1 of 2 positive 80 participants

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

3/8
Randomised
3/8
Double-Blind
2/8
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2006)
20
Study 2 (1991)
47
Study 3 (1993)
96
Study 4 (1998)
200
Study 5 (2010)
12
Study 6 (2017)
387
Study 7 (1984)
18
Study 8 (2017)
62

Research Timeline

When the studies were published

1
1984
1
1991
1
1993
1
1998
1
2006
1
2010
2
2017

All Studies

Detailed breakdown of each trial. Click to expand.

Fat Loss

1

Evaluate yohimbine on body fat in elite soccer players

2006 20 participants 21 days 20 mg/day
Human Study RCT Mixed

Study Type

Randomised Controlled Trial

Purpose

Evaluate yohimbine on body fat in elite soccer players

Dose

20 mg/day

Participants

20

Duration

21 days

Results

Yohimbine group reduced body fat by 1.8% vs 0.3% placebo; no change in muscle mass

How They Measured It

Body fat % via skinfold callipers

Read full study
2

Test yohimbine on weight loss in obese females

1991 47 participants 8 weeks 20 mg/day (4x5 mg)
Human Study Double-Blind Placebo Positive

Study Type

Double-Blind Placebo-Controlled Trial

Purpose

Test yohimbine on weight loss in obese females

Dose

20 mg/day (4x5 mg)

Participants

47

Duration

8 weeks

Results

Significant weight loss in yohimbine (−3.55 kg) vs placebo (−2.21 kg); fat mass preferentially decreased

How They Measured It

Body weight and fat by DEXA

Read full study
3

Assess yohimbine vs placebo for fat loss in overweight adults

1993 96 participants 8 weeks 18 mg/day
Human Study Double-Blind Placebo Positive

Study Type

Double-Blind Placebo-Controlled Trial

Purpose

Assess yohimbine vs placebo for fat loss in overweight adults

Dose

18 mg/day

Participants

96

Duration

8 weeks

Results

Yohimbine produced greater fat loss; statistically significant difference in body fat percentage

How They Measured It

Body weight, body fat %

Read full study

Sexual Function

4

Evaluate yohimbine for erectile dysfunction

1998 200 participants 4–8 weeks 15–30 mg/day
Human Study Positive

Study Type

Systematic Review

Purpose

Evaluate yohimbine for erectile dysfunction

Dose

15–30 mg/day

Participants

200

Duration

4–8 weeks

Results

Yohimbine significantly improved erectile function vs placebo; strongest in psychogenic ED

How They Measured It

Meta-analysis of erectile function scores across RCTs

Read full study

Exercise Performance

5

Investigate yohimbine on exercise performance and fat oxidation

2010 12 participants Acute 20 mg pre-exercise
Human Study RCT Positive

Study Type

Randomised Crossover Trial

Purpose

Investigate yohimbine on exercise performance and fat oxidation

Dose

20 mg pre-exercise

Participants

12

Duration

Acute

Results

Increased fat oxidation during moderate exercise; no significant change in VO2 max

How They Measured It

VO2 max, fat oxidation rate, RPE

Read full study
6

Evaluate yohimbine supplementation for weight loss

2017 387 participants 3–12 weeks 5–20 mg/day
Human Study Positive

Study Type

Systematic Review & Meta-Analysis

Purpose

Evaluate yohimbine supplementation for weight loss

Dose

5–20 mg/day

Participants

387

Duration

3–12 weeks

Results

Modest but significant reduction in body weight and fat mass; evidence quality rated moderate

How They Measured It

Pooled body weight and fat mass outcomes

Read full study

Anxiety & Adrenergic Effects

7

Characterise yohimbine adrenergic and anxiogenic effects

1984 18 participants Acute 20 mg single dose
Human Study Double-Blind Positive

Study Type

Double-Blind Crossover Trial

Purpose

Characterise yohimbine adrenergic and anxiogenic effects

Dose

20 mg single dose

Participants

18

Duration

Acute

Results

Significant increase in norepinephrine and systolic BP; elevated anxiety scores; dose-dependent

How They Measured It

Plasma norepinephrine, BP, anxiety rating scales

Read full study
8

Assess yohimbine effects on anxiety and cardiovascular parameters

2017 62 participants 4 weeks 10 mg twice daily
Human Study RCT Mixed

Study Type

Randomised Controlled Trial

Purpose

Assess yohimbine effects on anxiety and cardiovascular parameters

Dose

10 mg twice daily

Participants

62

Duration

4 weeks

Results

Yohimbine increased heart rate and anxiety ratings; some subjects discontinued due to side effects

How They Measured It

Heart rate, BP, anxiety questionnaires

Read full study

Frequently Asked Questions

Common questions about Yohimbine research

What does the research say about Yohimbine?

There are currently 8 peer-reviewed studies on Yohimbine (Pausinystalia yohimbe bark extract), involving 612 total participants. Research covers Fat Loss, Sexual Function, Energy and 1 more areas. The overall evidence strength is rated as Strong.

How strong is the evidence for Yohimbine?

The evidence is currently rated as "Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (8 human studies), and reported outcomes.

What health goals has Yohimbine been studied for?

Yohimbine has been researched for: Fat Loss, Sexual Function, Energy, Anxiety. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Yohimbine based on human trials?

Yes, 8 out of 8 studies are human trials. Human trials carry more weight in our evidence scoring system.